Newsroom
Sorted by: Latest
-
Almonty Commences Processing Operations at Sangdong Mine, Marking Transition to Saleable Tungsten Concentrate Production
DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced the commencement of processing plant throughput operations at its Sangdong Mine in Gangwon Province, South Korea. During June 2026, the Company began feeding stockpiled run-of-mine ore through its newly commissioned processing plant to produce saleable tungsten concentrate — a pivotal milest...
-
FrontView REIT Provides Second Quarter Investment Activity, Capital Markets Update and Update to Net Investment Guidance
DALLAS--(BUSINESS WIRE)--FrontView REIT, Inc. (“FrontView” or the “Company”) today provided an update on second quarter investment activity, capital markets activity and revised net investment guidance. “Our second quarter investment activity continues to highlight the quality and depth of the opportunities we are sourcing within the market,” said Steve Preston, Chairman and Chief Executive Officer. “Year-to-date, we have acquired more than $92 million of properties, including over $58 million...
-
Fortive Schedules Second Quarter 2026 Earnings Conference Call
EVERETT, Wash.,--(BUSINESS WIRE)--Fortive Corporation (“Fortive”) (NYSE: FTV) today announced that it will webcast its earnings conference call for the second quarter 2026 on Wednesday, July 29, 2026, beginning at 12:00 p.m. ET and lasting approximately one hour.The call and an accompanying presentation will be webcast on the "Investors" section of Fortive’s website, www.fortive.com, under "News & Events".You can access the conference call by dialing 877-407-3110 within the U.S. or +1 215-26...
-
INTENT Biologics Receives FDA Breakthrough Therapy Designation for PEP Biologic™ for its Phase 3 Ready Flagship Indication
ROCHESTER, Minn.--(BUSINESS WIRE)--INTENT Biologics Receives FDA Breakthrough Therapy Designation for PEP Biologic™ for its Phase 3 Ready Flagship Indication...
-
Gibraltar to Present at CJS Securities Annual New Ideas Summer Conference
BUFFALO, N.Y.--(BUSINESS WIRE)--Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the residential, agtech and infrastructure markets, today announced that Chairman and Chief Executive Officer Bill Bosway and Chief Financial Officer Joe Lovechio are scheduled to present at the CJS Securities Annual New Ideas Conference on Thursday, July 9, 2026 at 9:20 a.m. ET and hold meetings with investors that day. About Gibraltar Gibraltar is a leadi...
-
Sprinklr Announces Thomas Addis as Chief Revenue Officer
NEW YORK--(BUSINESS WIRE)--Thomas Addis will join Sprinklr as its Chief Revenue Officer, effective immediately....
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Klarna has received a favorable ruling in PriceRunner litigation, awarding damages of $1.97 billion
NEW YORK--(BUSINESS WIRE)--Klarna Group plc (NYSE: KLAR) today announces that the court has ruled in PriceRunner’s favor, awarding $1.97 billion in damages in an antitrust case brought by PriceRunner against Google. The award compensates for lost revenue caused by Google's preferential treatment of its own comparison-shopping service over independent price-comparison services, conduct that also drives up costs for consumers. "When markets work well, everyone benefits. Consumers get higher quali...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 30.06.2026 SCAR LN IE000BW2B3J3 50,002.00 USD 1,437,566.78 28.750 ...